I've decided that since no one on this site needs beauty hints, all of you being beautiful, what you really need are stock tips.
Jim Cramer does nightly Stock Market reviews in the United States on CNBC. In his youth, he was a Marxist. His hero was Lenin, whom he vaguely resembles.
He says, invest in Brazilian and Russian stock markets, as opposed to U.S. He says Russia is the 2d most capitalist country in the world. China is the First.
Cramer's Russian TV Stock Play
"The rise of capitalism in Russia has fueled the rapid growth of TV," Jim Cramer told fans of his "Mad Money" TV show Wednesday. Cramer thinks the best way to play the growing TV space is with CTC Media (CTCM), the fourth largest broadcaster in Russia. Cramer explained that CTCM owns 32 TV stations and operates two entertainment channels, one centered on the younger demographic and the other on women. CTC Media controls 12% of the Russian TV viewing audience and half of all advertising in the region is spent on TV commercials. CTC is also growing into Soviet satellites like Kazakhstan and Uzbekistan and Cramer thinks the company will benefit big from these emerging markets. Cramer's favorite part of CTC is their expected growth rate of 30% coupled with the stocks cheap valuation at 18 times this year's earnings. He advised investors to get into CTCM before Wall Street catches on to this opportunity.
Cramer Anointes Merck His #1 Dow Stock
Cramer called Merck (MRK) his next "catch-up" stock for a play on stocks that are lagging in their peer group. Recently, Merck lost $31 billion off its marketcap after the company was hit with negative reports surrounding its anti-cholesterol drug Vytorin - which it co-marketed with Schering-Plough (SGP). "I believe Merck's been beaten down way too much," said Cramer. "Just days after the negative study was released, Merck saw only modest dips in the prescription rates for Vytorin, indicating that the market may have overreacted to the news," he said. Cramer thinks the fall in Merck is absurd and now the estimates are just too low. He feels the drug sector is exactly the place to be in a slowing economic environment and Merck has a 3.7% dividend yield that provides investors a cushion of safety. Merck now trades at 11 times forward earnings and has several big drugs in the pipeline expected to bring in $4.6 billion in sales this year. The management team also has $5.1 billion ready to buyback stock. Cramer said if Merck traded back towards its historic value the stock would advance by 25%. Cramer called Merck his No. 1 pick in the Dow.
Jim Cramer does nightly Stock Market reviews in the United States on CNBC. In his youth, he was a Marxist. His hero was Lenin, whom he vaguely resembles.
He says, invest in Brazilian and Russian stock markets, as opposed to U.S. He says Russia is the 2d most capitalist country in the world. China is the First.
Cramer's Russian TV Stock Play
"The rise of capitalism in Russia has fueled the rapid growth of TV," Jim Cramer told fans of his "Mad Money" TV show Wednesday. Cramer thinks the best way to play the growing TV space is with CTC Media (CTCM), the fourth largest broadcaster in Russia. Cramer explained that CTCM owns 32 TV stations and operates two entertainment channels, one centered on the younger demographic and the other on women. CTC Media controls 12% of the Russian TV viewing audience and half of all advertising in the region is spent on TV commercials. CTC is also growing into Soviet satellites like Kazakhstan and Uzbekistan and Cramer thinks the company will benefit big from these emerging markets. Cramer's favorite part of CTC is their expected growth rate of 30% coupled with the stocks cheap valuation at 18 times this year's earnings. He advised investors to get into CTCM before Wall Street catches on to this opportunity.
Cramer Anointes Merck His #1 Dow Stock
Cramer called Merck (MRK) his next "catch-up" stock for a play on stocks that are lagging in their peer group. Recently, Merck lost $31 billion off its marketcap after the company was hit with negative reports surrounding its anti-cholesterol drug Vytorin - which it co-marketed with Schering-Plough (SGP). "I believe Merck's been beaten down way too much," said Cramer. "Just days after the negative study was released, Merck saw only modest dips in the prescription rates for Vytorin, indicating that the market may have overreacted to the news," he said. Cramer thinks the fall in Merck is absurd and now the estimates are just too low. He feels the drug sector is exactly the place to be in a slowing economic environment and Merck has a 3.7% dividend yield that provides investors a cushion of safety. Merck now trades at 11 times forward earnings and has several big drugs in the pipeline expected to bring in $4.6 billion in sales this year. The management team also has $5.1 billion ready to buyback stock. Cramer said if Merck traded back towards its historic value the stock would advance by 25%. Cramer called Merck his No. 1 pick in the Dow.